Cleared Traditional

K110223 - WAVEGUARD (TM) EEG CAP

K110223 is an FDA 510(k) clearance for WAVEGUARD (TM) EEG CAP, manufactured by Eemagine Medical Imaging Solutions GmbH. The device is a Class 2 Neurology device with product code GXY cleared through the Traditional 510(k) pathway after a 155-day FDA review.

K110223 · Eemagine Medical Imaging Solutions GmbH · Neurology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 2011
Decision
155d
Days
Class 2
Risk

K110223 is an FDA 510(k) clearance for the WAVEGUARD (TM) EEG CAP. Classified as Electrode, Cutaneous (product code GXY), Class II - Special Controls.

Submitted by Eemagine Medical Imaging Solutions GmbH (Naples, US). The FDA issued a Cleared decision on June 29, 2011 after a review of 155 days - an extended review cycle.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.1320 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Neurology review framework, consistent with the majority of Class II 510(k) submissions.

View all Eemagine Medical Imaging Solutions GmbH devices

FDA 510(k) Submission Details - K110223

510(k) Number K110223 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 25, 2011
Decision Date June 29, 2011
Days to Decision 155 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
7d slower than avg
Panel avg: 148d · This submission: 155d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

GXY Device Classification - Class 2, Special Controls

Product Code GXY Electrode, Cutaneous
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.1320
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - GXY Electrode, Cutaneous

All 185
Devices cleared under the same product code (GXY) and FDA review panel - the closest regulatory comparables to K110223.
LONG LIFE PADTM
K120516 · Omron Healthcare, Inc. · May 2012
NEUROTECH RECOVERY
K112934 · Bio-Medical Research, Ltd. · Jan 2012
LIFECARE CONDUCTIVE GARMENTS
K103719 · Everyway Medical Instruments Co.,Ltd · Aug 2011
AVIVAFIX CONDUCTIVE GARMENT-KNEE/SHOULDER/UPPER BACK, TYPE 40
K102614 · Bio-Medical Research, Ltd. · Jun 2011
SUPERIOR STARBURST REUSABLE SELF-ADHERING TENS/NMES/FES STIMULATING ELECTRODE
K100418 · Covidien · Sep 2010
DURA-STICK SELF-ADHESIVE ELECTRODES WITH ALOE
K091762 · Covidien · Dec 2009